ConductScience.org, home

Trial · NCT07884331

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Width of Keratinized GingivaBaseline to 3 months after surgery
Change in keratinized gingival width in millimeters between the preoperative baseline assessment and the three-month postoperative assessment. Keratinized gingival width will be measured between the mucogingival junction and the midpoint of the alveolar ridge using digital intraoral scans obtained with a 3Shape TRIOS 6 intraoral scanner and analyzed using 3D Slicer software.
SecondarySuccessful Closure of the Oro-Antral Communication14 days after surgery
Clinical success will be defined as complete closure of the oro-antral communication without persistent communication between the oral cavity and maxillary sinus. The proportion of successfully closed oro-antral communications will be calculated for each study group.
SecondaryPostoperative PainDay 0 through postoperative day 7Participants will record their daily maximum postoperative pain once daily in the afternoon using a visual analog scale from 0 to 10, where 0 represents no pain and 10 represents very severe pain.
SecondaryPostoperative SwellingDay 0 through postoperative day 7
Participants will record their daily maximum postoperative swelling once daily in the afternoon using a visual analog scale from 0 to 10, where 0 represents no swelling and 10 represents very severe swelling.
SecondaryPostoperative bleedingDay 0 through postoperative day 7
Participants will record their daily maximum postoperative bleeding once daily in the afternoon using a visual analog scale from 0 to 10, where 0 represents no postoperative bleeding and 10 represents very severe postoperative bleeding.
SecondaryNumber of Participants with Postoperative Wound dehiscence14 days after surgery
Presence or absence of postoperative separation of the sutured buccal and palatal soft tissues will be clinically assessed 14 days after surgery. Participants will be classified as having wound dehiscence if separation of the wound edges is observed. If wound dehiscence is present, its dimensions will additionally be quantified using the intraoral scan.
SecondaryDimensions of Postoperative Wound Dehiscence14 days after surgery
Among participants with postoperative wound dehiscence, the maximum dimensions of the separation of the sutured buccal and palatal soft tissues will be measured in milimeters using an intraoral scan 14 days after surgerx.
SecondaryNumber of Participants with Recurrent or Persistent Oro-Antral CommunicationUp to 3 months after surgeryOccurrence of a persistent or recurrent communication between the oral cavity and maxillary sinus during follow-up will be recorded.
SecondaryNumber of Participants with Postoperative Sinusitis or Infection14 days after surgery
Occurrence of clinically diagnosed postoperative maxillary sinusitis or local infection at the follow-up examination after 14 days will be recorded. Clinical signs and symptoms may include facial pain, pressure sensation, purulent nasal discharge, intraoral purulent drainage, fever, or other clinically relevant signs of infection.
SecondaryReoperation rate14 days after surgeryPercentage of participants in each study group requiring surgical revision because of insufficient closure of the oro-antral communication.
SecondaryOperative timeIntraoperatively on Day 0Duration of the surgical procedure measured from the first surgical incision to completion of the final suture, recorded in minutes and seconds.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07884331/registered